Australia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Australia

In 2022, the Australian prophylactic medicaments containing insulin market was finally on the rise to reach $X for the first time since 2019, thus ending a two-year declining trend. Over the period under review, consumption, however, continues to indicate a slight reduction. Over the period under review, the market hit record highs at $X in 2013; however, from 2014 to 2022, consumption failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Australia

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from Australia; which is down by -57.2% compared with the previous year. Overall, exports saw a pronounced setback. The pace of growth appeared the most rapid in 2021 when exports increased by 267%. The exports peaked at X tons in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports declined to $X in 2022. In general, exports continue to indicate a deep slump. The growth pace was the most rapid in 2018 with an increase of 130% against the previous year. As a result, the exports attained the peak of $X. From 2019 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

New Zealand (X tons) was the main destination for prophylactic medicaments containing insulin exports from Australia, accounting for a 70% share of total exports. Moreover, prophylactic medicaments containing insulin exports to New Zealand exceeded the volume sent to the second major destination, the United Arab Emirates (X tons), fourfold.

From 2012 to 2022, the average annual rate of growth in terms of volume to New Zealand amounted to -7.4%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United Arab Emirates (+152.4% per year) and Thailand (+2,777.6% per year).

In value terms, New Zealand ($X), the United Arab Emirates ($X) and Thailand ($X) appeared to be the largest markets for prophylactic medicaments containing insulin exported from Australia worldwide, together comprising 94% of total exports.

Thailand, with a CAGR of +877.4%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced mixed trend patterns.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, with an increase of 115% against the previous year. Overall, the export price, however, recorded a slight descent. The export price peaked at $X per ton in 2018; however, from 2019 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while the average price for exports to Thailand ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to New Zealand (-3.6%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Australia

In 2022, after two years of decline, there was significant growth in purchases abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume increased by 18% to X tons. In general, imports, however, recorded a pronounced shrinkage. Imports peaked at X tons in 2015; however, from 2016 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. Over the period under review, imports, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 when imports increased by 16%. Imports peaked at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.

Imports by Country

Brazil (X tons), Germany (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Australia, with a combined 86% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Denmark (with a CAGR of +5.8%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Brazil ($X), Germany ($X) and Denmark ($X) were the largest prophylactic medicaments containing insulin suppliers to Australia, with a combined 86% share of total imports.

In terms of the main suppliers, Denmark, with a CAGR of +11.9%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, shrinking by -1.5% against the previous year. Overall, import price indicated moderate growth from 2012 to 2022: its price increased at an average annual rate of +3.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price increased by +1.3% against 2020 indices. The growth pace was the most rapid in 2018 an increase of 49%. As a result, import price reached the peak level of $X per ton. From 2019 to 2022, the average import prices remained at a somewhat lower figure.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from Italy ($X per ton) and Brazil ($X per ton), while the price for the United States ($X per ton) and Denmark ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (+12.3%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :